Literature DB >> 24744023

Traumatic optic neuropathy and second optic nerve injuries.

William Marshall Guy1, Charles N S Soparkar2, Eugene L Alford3, James R Patrinely4, Mirwat S Sami5, Robert B Parke1.   

Abstract

IMPORTANCE: Current controversy about the primary treatment of traumatic optic neuropathy (TON) has anchored on final vision following injury, but, to our knowledge, no study has examined the effect of different treatments on regaining and protecting optic nerve reserve or on the outcome of second optic nerve injuries.
OBJECTIVE: To assess vision improvement in patients treated by various methods who have a second incidence of TON. DESIGN, SETTING, AND PARTICIPANTS: Retrospective medical record review of 12 patients with a second TON seen in an 18-year period (mean follow-up, 11.3 months) at a single tertiary care oculoplastic practice.
INTERVENTIONS: Observation, high-dose corticosteroids, optic nerve decompression, or high-dose corticosteroids plus optic nerve decompression. MAIN OUTCOMES AND MEASURES: Change in vision on the Snellen eye chart. RESULTS All second TON events involved the same-side optic nerve as initially injured, and with observation alone, corticosteroids, or corticosteroids and partial optic canal decompression, all patients had vision improvement after their initial injury (P = .004). However, following the second optic nerve injury, most patients' vision fell to the pretreatment level of the first injury, and subsequent management of the second injury with corticosteroids and/or optic canal decompression provided little or no vision return (P = .05). In contrast, optic canal decompressions performed for 91 primary TON injuries resulted in 82.4% having some degree of vision improvement. CONCLUSIONS AND RELEVANCE: Patients with TON may have a second optic nerve insult, and vision recovery from the second event may be limited regardless of primary treatment choice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24744023     DOI: 10.1001/jamaophthalmol.2014.82

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  11 in total

1.  Langerhans cell histiocytosis causing acute optic neuropathy.

Authors:  Jin Woo Bae; Yong Hwy Kim; Seung-Ki Kim; Kyu-Chang Wang; Hee-Young Shin; Hyoung Jin Kang; Sung-Hye Park; Ji Hoon Phi
Journal:  Childs Nerv Syst       Date:  2015-01-08       Impact factor: 1.475

2.  Combination analysis on the impact of the initial vision and surgical time for the prognosis of indirect traumatic optic neuropathy after endoscopic transnasal optic canal decompression.

Authors:  Wei Yan; Jingquan Lin; Wanglu Hu; Qun Wu; Jianmin Zhang
Journal:  Neurosurg Rev       Date:  2020-02-25       Impact factor: 3.042

Review 3.  Traumatic optic neuropathy: a review of current studies.

Authors:  Bin Chen; Hengsen Zhang; Qing Zhai; Huaipeng Li; Chunxia Wang; Yong Wang
Journal:  Neurosurg Rev       Date:  2022-01-16       Impact factor: 3.042

4.  Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.

Authors:  Brian C Tse; Galina Dvoriantchikova; Wensi Tao; Ryan A Gallo; John Y Lee; Dmitry Ivanov; David T Tse; Daniel Pelaez
Journal:  Exp Eye Res       Date:  2020-08-03       Impact factor: 3.467

Review 5.  An evolving perspective of endoscopic transnasal optic canal decompression for traumatic optic neuropathy in clinic.

Authors:  Jingquan Lin; Wanglu Hu; Qun Wu; Jianmin Zhang; Wei Yan
Journal:  Neurosurg Rev       Date:  2019-11-22       Impact factor: 3.042

6.  Fasudil alleviates traumatic optic neuropathy by inhibiting Rho signaling pathway.

Authors:  Jianglong Yu; Shiying Lan; Ruijia Wang; Aba Maier; Xinping Luan
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  A Novel Mouse Model of Traumatic Optic Neuropathy Using External Ultrasound Energy to Achieve Focal, Indirect Optic Nerve Injury.

Authors:  Wensi Tao; Galina Dvoriantchikova; Brian C Tse; Steven Pappas; Tsung-Han Chou; Manuel Tapia; Vittorio Porciatti; Dmitry Ivanov; David T Tse; Daniel Pelaez
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

8.  Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy.

Authors:  Brian C Tse; Galina Dvoriantchikova; Wensi Tao; Ryan A Gallo; John Y Lee; Steven Pappas; Roberta Brambilla; Dmitry Ivanov; David T Tse; Daniel Pelaez
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

9.  mTORC2 activation protects retinal ganglion cells via Akt signaling after autophagy induction in traumatic optic nerve injury.

Authors:  Yao-Tseng Wen; Jia-Rong Zhang; Kishan Kapupara; Rong-Kung Tsai
Journal:  Exp Mol Med       Date:  2019-08-13       Impact factor: 8.718

10.  Retinal Ganglion Cells Die by Necroptotic Mechanisms in a Site-Specific Manner in a Rat Blunt Ocular Injury Model.

Authors:  Chloe N Thomas; Adam M Thompson; Zubair Ahmed; Richard J Blanch
Journal:  Cells       Date:  2019-11-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.